- « Previous
- Clinical Pharmacology
- Next »
Ditropan XL
Clinical Pharmacology
Clinical Pharmacology
Ditropan XL
![]() |
| Study 2 | N | DITROPAN*XL | N | oxybutynin |
| Mean Baseline | 53 | 27.6 | 52 | 23.0 |
| Mean (SD) Change from Baseline† | 53 | -17.6(11.9) | 52 | -19.4(11.9) |
| 95% Confidence Interval for Difference | (-2.8,6.5) | |||
| (DITROPAN*XL-oxybutynin) | ||||
| † Covariate adjusted mean with missing observations set to baseline values | ||||
![]() |
| Study 3 | N | DITROPAN* XL | N | oxybutynin |
| Mean Baseline | 111 | 18.9 | 115 | 19.5 |
| Mean (SD) Change from Baseline† | 111 | -14.5(8.7) | 115 | -13.8(8.6) |
| 95% Confidence Interval for Difference | (-3.0,1.6)** | |||
| 1 (DITROPAN* XL - oxybutynin) | ||||
| ** The difference between DITROPAN* XL and
oxybutynin fulfilled the criteria for comparable efficacy. †Covariate adjusted mean with missing observations set to baseline values |
||||
![]() |
Brand Name: Ditropan XL
Generic Name: Oxybutynin Chloride Extended Release Tablets
Generic Name: Oxybutynin Chloride Extended Release Tablets
- « Previous
- Clinical Pharmacology
- Next »
WebMD Resources
Exercise for Urinary Incontinence
Like millions, Mary Lou Retton has urinary incontinence. There are no medications but pelvic muscle exercises often help. See more WebMD Videos »
WebMD Daily
Get breaking medical news.



